Kidney International

FIGURE 2

FROM:

Impairment of phenylalanine conversion to tyrosine inend-stage renal disease causing tyrosine deficiency

YVES BOIRIE, ROBERT ALBRIGHT, MAUREEN BIGELOW and K SREEKUMARAN NAIR

BACK TO ARTICLE

Figure 2.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Comparison of phenylalanine conversion to tyrosine as a function of phenylalanine flux and phenylalanine concentration and tyrosine/phenylalanine ration in control and end-stage renal disease (ESRD) subjects. (A) Phenylalanine to tyrosine/phenylalanine flux. (B) Phenylalanine to tyrosine/phenylalanine concentration. (C) Tyrosine/phenylalanine. All these parameters were lower in ESRD patients than in the control subjects.

BACK TO ARTICLE